QTMeds

Drug Database Monograph

RYSTIGGO 140 mg/mL

PENDING REVIEW

Active Ingredient: ROZANOLIXIZUMAB

QTc Interval Status:

neutral

Clinical Description (Database Summary)

Scientific Sources / References

Analyse RCP (Automatique), id : 68822785

← Back to Prescription Analyzer